Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Chris R. Prostko

Evaluating Risks, Costs, and Benefits of New and Emerging Therapies to Optimize Outcomes in Multiple Sclerosis

Journal of Managed Care Pharmacy

English

Related publications

Risks vs Benefits of Glatiramer Acetate: A Changing Perspective as New Therapies Emerge for Multiple Sclerosis

Therapeutics and Clinical Risk Management

English

Emerging Therapies for Relapsing Multiple Sclerosis

Archives of Neurology

English

Multiple Sclerosis and Complementary Therapies

Journal of Academic Research in Nursing

English

Systemic Sclerosis Pathogenesis and Emerging Therapies, Beyond the Fibroblast

BioMed Research International

Molecular Biology

English

Evaluating the Risks and Benefits of Participation in High-School Football

AMA journal of ethics

English

Benefits, Risks and Costs of Immunization for Measles, Mumps and Rubella.

American Journal of Public Health

Occupational Health

English

Emerging Immunopharmacological Targets in Multiple Sclerosis

Journal of the Neurological Sciences

English

New Insights Into the Burden and Costs of Multiple Sclerosis in Europe: Results for Sweden

Multiple Sclerosis

English

New Insights Into the Burden and Costs of Multiple Sclerosis in Europe: Results for Switzerland

Multiple Sclerosis

English